US court upholds AZ injunction blocking Apotex's asthma generic
This article was originally published in Scrip
Executive Summary
A federal appeals court has upheld AstraZeneca’s injunction to prevent Apotex from launching a generic version of the AZ asthma treatment Pulmicort Respules (budesonide inhalation suspension).